P435 HER2/neu-derived peptide conjugated to liposomes containing DOPE as an effective prophylactic vaccine formulation for breast cancer-Reference-Cited by-同舟云学术

P435 HER2/neu-derived peptide conjugated to liposomes containing DOPE as an effective prophylactic vaccine formulation for breast cancer

Published:2019-03-04 Issue:1 Volume:47 Page:664-672
ISSN:2169-1401
Container-title:Artificial Cells, Nanomedicine, and Biotechnology
language:en
Short-container-title:Artificial Cells, Nanomedicine, and Biotechnology

Author:

Farzad Niloofar¹²,Barati Nastaran¹³²,Momtazi-Borojeni Amir Abbas⁴,Yazdani Mona¹,Arab Atefeh¹³²,Razazan Atefeh⁵,Shariat Sheida¹,Mansourian Mercedeh¹²,Abbasi Azam¹,Saberi Zahra¹,Badiee Ali¹³²,Jalali Seyed Amir⁶,Jaafari Mahmoud Reza¹³²

Affiliation:

1. Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran;

2. Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Science, Mashhad, Iran;

3. Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran;

4. Nanotechnology Research Center, Department of Medical Biotechnology, Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran;

5. Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran;

6. Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Funder

Biotechnology Research Center and Nanotechnology Research Center, Mashhad University of Medical Sciences

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Biomedical Engineering,General Medicine,Medicine (miscellaneous),Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21691401.2019.1576702

Reference62 articles.

1. Immunotherapy of cancer

2. Cancer Immunotherapy

3. Immunotherapy of Cancer

4. Eradication of Established Tumors by CD8+ T Cell Adoptive Immunotherapy

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoantigens and cancer-testis antigens as promising vaccine candidates for triple-negative breast cancer: Delivery strategies and clinical trials;Journal of Controlled Release;2024-06

2. Lipid Nanoparticles: Versatile Drug Delivery Vehicles for Traversing the Blood Brain Barrier to Treat Brain Cancer;Advanced Functional Materials;2024-05-22

3. Canine Mammary Tumors: Classification, Biomarkers, Traditional and Personalized Therapies;International Journal of Molecular Sciences;2024-03-01

4. Recent advances in liposome-based targeted cancer therapy;Journal of Liposome Research;2023-10-09

5. Improving the efficacy of peptide vaccines in cancer immunotherapy;International Immunopharmacology;2023-10